Status: current, Defined. Date: 30-Nov 2017. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 2976551000168117 | Darzalex (daratumumab 400 mg / 20 mL) injection, 20 mL vial (trade product unit of use) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 2976561000168115 | Darzalex 400 mg/20 mL injection, 20 mL vial | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Darzalex (daratumumab 400 mg / 20 mL) injection, 20 mL vial (trade product unit of use) | has manufactured dose form | injection | true | Inferred relationship | Some | ||
| Darzalex (daratumumab 400 mg / 20 mL) injection, 20 mL vial (trade product unit of use) | Is a | Darzalex | true | Inferred relationship | Some | ||
| Darzalex (daratumumab 400 mg / 20 mL) injection, 20 mL vial (trade product unit of use) | Is a | daratumumab 400 mg/20 mL injection, vial | true | Inferred relationship | Some | ||
| Darzalex (daratumumab 400 mg / 20 mL) injection, 20 mL vial (trade product unit of use) | Is a | trade product unit of use | true | Inferred relationship | Some | ||
| Darzalex (daratumumab 400 mg / 20 mL) injection, 20 mL vial (trade product unit of use) | has manufactured dose form | concentrated injection | false | Inferred relationship | Some | ||
| Darzalex (daratumumab 400 mg / 20 mL) injection, 20 mL vial (trade product unit of use) | has unit of use | vial | true | Inferred relationship | Some | 332583765 | |
| Darzalex (daratumumab 400 mg / 20 mL) injection, 20 mL vial (trade product unit of use) | has intended active ingredient | daratumumab | true | Inferred relationship | Some | 332583764 | |
| Darzalex (daratumumab 400 mg / 20 mL) injection, 20 mL vial (trade product unit of use) | has Australian BoSS | daratumumab | true | Inferred relationship | Some | 332583764 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Darzalex 400 mg/20 mL injection, 20 mL vial | has TPUU | True | Darzalex (daratumumab 400 mg / 20 mL) injection, 20 mL vial (trade product unit of use) | Inferred relationship | Some | 1 |
| Darzalex 400 mg/20 mL injection, 20 mL vial | has TPUU | True | Darzalex (daratumumab 400 mg / 20 mL) injection, 20 mL vial (trade product unit of use) | Inferred relationship | Some | 1 |
Reference Sets
Trade product unit of use reference set
FHIR